Search results
EyePoint Pharmaceuticals’ stock plunges as eye treatment fails to meet trial goal
Market Watch· 2 days agodropped nearly 30% in premarket trading Monday after the company said its experimental...
Looking for something to do in Bartlesville? We've got you covered
Examiner Enterprise via Yahoo News· 4 hours agoTriad Eye Clinic holds eye screenings for seniors 55+ at Elder Care. Testing and information provided by a licensed optometrist for glaucoma, cataracts, diabetic eye
HanAll Biopharma initiates Phase III DED treatment trial
Clinical Trials Arena via Yahoo Finance· 2 days agoHanAll Biopharma has commenced the Phase III VELOS-4 trial for tanfanercept, a new topical...
EyePoint Pharmaceuticals Trial of Duravyu in Diabetic Eye Disease Fails to Meet Primary Endpoint
Market Watch· 2 days agoEyePoint Pharmaceuticals said that topline results from a Phase 2 clinical trial evaluating Duravyu in non-proliferative diabetic retinopathy didn't meet the pre-specified primary endpoint.
Regeneron Reverses On Better-Than-Feared Eylea Sales As Patent Expiration Looms
Investor's Business Daily· 6 days agoRegeneron stock jumped Thursday, bolstered by strong sales of a high-dose version of its blockbuster...
3 Biotech Stocks With the Potential to Make You an Overnight Millionaire
InvestorPlace· 4 days agoThis excellent opportunity that biotech stocks present can provide investors with potentially...
NovaBay reports record Avenova sales on Amazon By Investing.com
Investing.com· 20 hours agoNovaBay Pharmaceuticals, Inc. (NYSE American: NBY) has announced a significant uptick in sales for...
Are Egg Whites Actually Healthy? Here's What To Know
Health.com· 1 day agoEgg white is the clear liquid inside eggs that form around the yellow yolk. Both egg whites and egg yolk are healthy as they are highly nutritious. Egg...
Kodiak Sciences Inc (KOD) Shares Up Despite Recent Market Volatility – News Heater
NewsHeater· 6 days agoZacks Investment Research reported 2024-04-04 that Kodiak (KOD) initiates a phase III study evaluating tarcocimab in diabetic retinopathy, which is expected to serve as the basis for a regulatory ...
Stock Market Rallies On Fed, Jobs Report, Apple: Weekly Review
Investor's Business Daily· 5 days agoRegeneron Pharmaceuticals missed on both metrics, with EPS down 5% and sales off 1% to $3.15...